Trial Profile
A single centre experience with tocilizumab for steroid-refractory graft-versus-host disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2014
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 21 Oct 2014 New trial record